Evidence map›Paper›PMID 37737191›Full record

ArticleActa neuropathologica communications2023

TDP43 pathology in chronic traumatic encephalopathy retinas.

Ragini Phansalkar, Vanessa S Goodwill, Jeffrey J Nirschl, Chiara De Lillo, Jihee Choi, Elizabeth Spurlock, David G Coughlin, Donald Pizzo, Christina J Sigurdson, Annie Hiniker and 3 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Neurotrauma: 2024 update.Free neuropathology · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Ragini PhansalkarSchool of Medicine, Stanford University, Stanford, CA, USA.
Vanessa S GoodwillDepartment of Pathology, University of California, San Diego, La Jolla, CA, USA.
Jeffrey J NirschlDepartments of Ophthalmology and Pathology, Stanford University, Stanford, CA, USA.
Chiara De LilloVita-Salute San Raffaele University, Milan, Italy.
Jihee ChoiThe University of Texas Southwestern Medical Center, Dallas, TX, USA.
Elizabeth SpurlockBoston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, MA, USA.
David G CoughlinDepartment of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
Donald PizzoDepartment of Pathology, University of California, San Diego, La Jolla, CA, USA.
Christina J SigurdsonDepartment of Pathology, University of California, San Diego, La Jolla, CA, USA.
Annie HinikerDepartment of Pathology, University of California, San Diego, La Jolla, CA, USA.
Victor E AlvarezBoston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, MA, USA.
Ann C MckeeBoston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, MA, USA.
Jonathan H LinDepartments of Ophthalmology and Pathology, Stanford University, Stanford, CA, USA. Jonathan.H.Lin@stanford.edu.ORCID http://orcid.org/0000-0002-7438-6941
University of California San Diego · USBoston University · USStanford University · USThe University of Texas Southwestern Medical Center · USVA Palo Alto Health Care System · USVita-Salute San Raffaele University · IT

Funding

UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DOUGLAS R GALASKO · 2019 to 2026
$34.9M
Stanford Alzheimer's Disease Research CenterAdmin Supp: Developing iPSC models for AD and PDP30AG066515 · NIA · STANFORD UNIVERSITY · PI ELIZABETH MORMINO · 2020 to 2026
$29.0M
RL5: Research Education CoreP30AG072978 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Ann C. McKee · 2021 to 2026
$25.6M
Traumatic Brain Injury and Repetitive Head Impacts: Contributions to AD/ADRD and CTE Neuropathology and Resulting Clinical SyndromesU54NS115266 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MCKEE, ANN C. · 2019 to 2023
$10.3M
Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Jeffrey L Goldberg · 2017 to 2026
$8.0M
Mechanisms of Prion Aggregation and Species BarriersR01NS069566 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ESKO, JEFFREY D, RAVITS, JOHN · 2011 to 2025
$5.7M
Mechanisms of Prion SpreadR01NS076896 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SIGURDSON, CHRISTINA · 2012 to 2021
$3.4M
Epigenetic changes in synaptic and inflammatory genes involved in the age-dependent development of Alzheimer's disease pathologies andcognitive declineRF1AG054156 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA, RYU, HOON · 2016 to 2018
$3.4M
Protein Homeostasis and Proteotoxicity MechanismsR01NS088485 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LIN, JONATHAN · 2015 to 2024
$3.0M
Mechanisms of Prion Spread and Neuronal ToxicityR37NS076896 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Christina Sigurdson · 2023 to 2026
$2.6M
Late Pathologies of Exposure to Repetitive Head Impacts from Contact Sports: White Matter and Vascular Contributions to Cognitive Impairment, Dementia, and Neuropsychiatric SymptomsRF1NS122854 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ALOSCO, MICHAEL, MCKEE, ANN C. · 2021 to 2021
$2.3M
Molecular basis of prion protein-induced neurodegenerationRF1NS121992 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SIGURDSON, CHRISTINA · 2021 to 2023
$1.7M
BLRD VA I01 BX005161NEI NIH HHS P30 EY026877NIA NIH HHS P30 AG062429NIA NIH HHS P30 AG066515NIA NIH HHS P30 AG072978NIA NIH HHS RF1 AG054156NINDS NIH HHS K23 NS102399NINDS NIH HHS R01 NS069566NINDS NIH HHS R01 NS076896NINDS NIH HHS R01 NS088485NINDS NIH HHS R21 NS135426NINDS NIH HHS R37 NS076896NINDS NIH HHS RF1 NS121992NINDS NIH HHS RF1 NS122854NINDS NIH HHS U54 NS115266
6 · The paper itself

Abstract

Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease associated with repetitive head trauma. Brain pathology in CTE is characterized by neuronal loss, gliosis, and a distinctive pattern of neuronal accumulation of hyper-phosphorylated tau (p-tau) and phospho-TDP43 (p-TDP43). Visual anomalies have been reported by patients with CTE, but the ocular pathology underlying these symptoms is unknown. We evaluated retinal pathology in post-mortem eyes collected from 8 contact sport athletes with brain autopsy-confirmed stage IV CTE and compared their findings to retinas from 8 control patients without CTE and with no known history of head injury. Pupil-optic nerve cross sections were prepared and stained with hematoxylin and eosin (H&E), p-tau, p-TDP43, and total TDP43 by immunohistochemistry. No significant retinal degeneration was observed in CTE eyes compared to control eyes by H&E. Strong cytoplasmic p-TDP43 and total TDP43 staining was found in 6/8 CTE eyes in a subset of inner nuclear layer interneurons (INL) of the retina, while only 1/8 control eyes showed similar p-TDP43 pathology. The morphology and location of these inner nuclear layer interneurons were most compatible with retinal horizontal cells, although other retinal cell types present in INL could not be ruled out. No p-tau pathology was observed in CTE or control retinas. These findings identify novel retinal TDP43 pathology in CTE retinas and support further investigation into the role of p-TDP43 in producing visual deficits in patients with CTE.

Indexed as

Chronic Traumatic EncephalopathyCraniocerebral TraumaNeurodegenerative DiseasesRetinal DegenerationBrainEosine Yellowish-(YS)HumansRetinaEosine Yellowish-(YS)Chronic traumatic encephalopathy (CTE)Eye pathologyInner nuclear layerRetinaTauTDP43

Identifiers

PMID37737191
PMCPMC10515050
OpenAlexW4386944019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.